Finding valuable therapeutic interventions for prostate cancer has long guided the research of Dr. Feng Yang's lab at Baylor College of Medicine. In a study published in the Proceedings of the National Academy of Sciences, ...
Oct 17, 2022
0
117
Cancer Research UK scientists have revealed a completely new route by which male androgen hormones fuel the growth of prostate cancer, raising the prospect that existing drugs could be used to treat the disease.
Aug 14, 2012
0
0
Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. ...
Mar 23, 2012
0
1
Failure of hormone deprivation therapy, which is used to slow prostate cancer in patients, leads to castration-resistant prostate cancer, a lethal form of advanced disease with limited treatment options.
Mar 10, 2017
0
26
Cancer is an evolutionary disease. The same forces that turned dinosaurs into birds turn normal cells into cancer: genetic mutations and traits that confer a survival advantage.
May 2, 2023
0
6
Resistance or strength training protects against the development of muscle pain in mice—and does so by activating androgen receptors, reports a basic science study in PAIN, the official publication of the International ...
Mar 31, 2022
0
10
Patients with castration-resistant prostate cancer had limited side effects and in many cases a drop in prostate-specific antigen expression with galeterone (TOK-001), a small-molecule oral drug, according to phase I data ...
Apr 1, 2012
0
0
Low levels of testosterone in men could increase their risk of developing diabetes, a study suggests.
May 4, 2012
0
0
According to new findings published in Science Translational Medicine, Cleveland Clinic researchers have identified a promising drug target for treating and preventing aggressive, drug-resistant prostate cancer.
May 26, 2021
0
19
A new targeted therapy for prostate cancer halts tumor growth in animals with advanced prostate cancer that is resistant to hormone therapy, a new study finds. The results will be presented Saturday at The Endocrine Society's ...
Jun 6, 2011
0
1
